CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CNBC Top News·2h·Media
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
TickersCVSChannelsstocksCountriesusaCategoriespharma
Open original source ↗Published
5/28/2026, 11:58:27 AM
Fetched
5/28/2026, 12:08:04 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
media · 60/100
Language
en